The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel

Kevin P. Bliden, Joseph DiChiara, Lookman Lawal, Anand Singla, Mark J. Antonino, Brian A. Baker, William L. Bailey, Udaya S. Tantry, Paul A. Gurbel

Research output: Contribution to journalArticle

Abstract

Objectives: The purpose of this study was to examine the effect of cigarette smoking on the platelet response to clopidogrel. Background: Response variability to clopidogrel therapy has been demonstrated. Clopidogrel is metabolically activated by several hepatic cytochrome P450 (CYP) isoenzymes, including CYP1A2. Cigarette smoking induces CYP1A2 and may, therefore, enhance the conversion of clopidogrel to its active metabolite. Methods: Among 259 consecutive patients undergoing elective coronary stenting; 120 were on chronic clopidogrel therapy and were not loaded; and 139 were clopidogrel naïve and were loaded with 600 mg. There were 104 current smokers (CS) and 155 nonsmokers (NS). The adenosine diphosphate (ADP)-stimulated platelet aggregation (PA) was assessed by conventional aggregometry. The ADP-stimulated total and active glycoprotein (GP) IIb/IIIa expression were assessed with flow cytometry. Low PA was defined as the lowest quartile of 5 μmol/l ADP-induced post-treatment PA. Results: Current smokers on chronic clopidogrel therapy displayed significantly lower PA and ADP-stimulated active GP IIb/IIIa expression compared with NS (p ≤ 0.0008 for both). Similarly, CS treated with 600 mg of clopidogrel displayed greater platelet inhibition and lower active GP IIb/IIIa expression compared with NS (p ≤ 0.05). In a multivariate Cox regression analysis, current smoking was an independent predictor of low PA (p = 0.0001). Conclusion: Clopidogrel therapy in CS is associated with increased platelet inhibition and lower aggregation as compared with NS. The mechanism of the smoking effect deserves further study and may be an important cause of response variability to clopidogrel therapy.

Original languageEnglish (US)
Pages (from-to)531-533
Number of pages3
JournalJournal of the American College of Cardiology
Volume52
Issue number7
DOIs
StatePublished - Aug 12 2008

Fingerprint

clopidogrel
Blood Platelets
Smoking
Platelet Aggregation
Adenosine Diphosphate
Platelet Glycoprotein GPIIb-IIIa Complex
Cytochrome P-450 CYP1A2
Therapeutics
Inhibition (Psychology)

Keywords

  • clopidogrel
  • platelets
  • smoking
  • stenting

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Bliden, K. P., DiChiara, J., Lawal, L., Singla, A., Antonino, M. J., Baker, B. A., ... Gurbel, P. A. (2008). The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. Journal of the American College of Cardiology, 52(7), 531-533. https://doi.org/10.1016/j.jacc.2008.04.045

The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. / Bliden, Kevin P.; DiChiara, Joseph; Lawal, Lookman; Singla, Anand; Antonino, Mark J.; Baker, Brian A.; Bailey, William L.; Tantry, Udaya S.; Gurbel, Paul A.

In: Journal of the American College of Cardiology, Vol. 52, No. 7, 12.08.2008, p. 531-533.

Research output: Contribution to journalArticle

Bliden, KP, DiChiara, J, Lawal, L, Singla, A, Antonino, MJ, Baker, BA, Bailey, WL, Tantry, US & Gurbel, PA 2008, 'The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel', Journal of the American College of Cardiology, vol. 52, no. 7, pp. 531-533. https://doi.org/10.1016/j.jacc.2008.04.045
Bliden, Kevin P. ; DiChiara, Joseph ; Lawal, Lookman ; Singla, Anand ; Antonino, Mark J. ; Baker, Brian A. ; Bailey, William L. ; Tantry, Udaya S. ; Gurbel, Paul A. / The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel. In: Journal of the American College of Cardiology. 2008 ; Vol. 52, No. 7. pp. 531-533.
@article{007ca5b252aa4d90bd474d03afb3a8d7,
title = "The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel",
abstract = "Objectives: The purpose of this study was to examine the effect of cigarette smoking on the platelet response to clopidogrel. Background: Response variability to clopidogrel therapy has been demonstrated. Clopidogrel is metabolically activated by several hepatic cytochrome P450 (CYP) isoenzymes, including CYP1A2. Cigarette smoking induces CYP1A2 and may, therefore, enhance the conversion of clopidogrel to its active metabolite. Methods: Among 259 consecutive patients undergoing elective coronary stenting; 120 were on chronic clopidogrel therapy and were not loaded; and 139 were clopidogrel na{\"i}ve and were loaded with 600 mg. There were 104 current smokers (CS) and 155 nonsmokers (NS). The adenosine diphosphate (ADP)-stimulated platelet aggregation (PA) was assessed by conventional aggregometry. The ADP-stimulated total and active glycoprotein (GP) IIb/IIIa expression were assessed with flow cytometry. Low PA was defined as the lowest quartile of 5 μmol/l ADP-induced post-treatment PA. Results: Current smokers on chronic clopidogrel therapy displayed significantly lower PA and ADP-stimulated active GP IIb/IIIa expression compared with NS (p ≤ 0.0008 for both). Similarly, CS treated with 600 mg of clopidogrel displayed greater platelet inhibition and lower active GP IIb/IIIa expression compared with NS (p ≤ 0.05). In a multivariate Cox regression analysis, current smoking was an independent predictor of low PA (p = 0.0001). Conclusion: Clopidogrel therapy in CS is associated with increased platelet inhibition and lower aggregation as compared with NS. The mechanism of the smoking effect deserves further study and may be an important cause of response variability to clopidogrel therapy.",
keywords = "clopidogrel, platelets, smoking, stenting",
author = "Bliden, {Kevin P.} and Joseph DiChiara and Lookman Lawal and Anand Singla and Antonino, {Mark J.} and Baker, {Brian A.} and Bailey, {William L.} and Tantry, {Udaya S.} and Gurbel, {Paul A.}",
year = "2008",
month = "8",
day = "12",
doi = "10.1016/j.jacc.2008.04.045",
language = "English (US)",
volume = "52",
pages = "531--533",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel

AU - Bliden, Kevin P.

AU - DiChiara, Joseph

AU - Lawal, Lookman

AU - Singla, Anand

AU - Antonino, Mark J.

AU - Baker, Brian A.

AU - Bailey, William L.

AU - Tantry, Udaya S.

AU - Gurbel, Paul A.

PY - 2008/8/12

Y1 - 2008/8/12

N2 - Objectives: The purpose of this study was to examine the effect of cigarette smoking on the platelet response to clopidogrel. Background: Response variability to clopidogrel therapy has been demonstrated. Clopidogrel is metabolically activated by several hepatic cytochrome P450 (CYP) isoenzymes, including CYP1A2. Cigarette smoking induces CYP1A2 and may, therefore, enhance the conversion of clopidogrel to its active metabolite. Methods: Among 259 consecutive patients undergoing elective coronary stenting; 120 were on chronic clopidogrel therapy and were not loaded; and 139 were clopidogrel naïve and were loaded with 600 mg. There were 104 current smokers (CS) and 155 nonsmokers (NS). The adenosine diphosphate (ADP)-stimulated platelet aggregation (PA) was assessed by conventional aggregometry. The ADP-stimulated total and active glycoprotein (GP) IIb/IIIa expression were assessed with flow cytometry. Low PA was defined as the lowest quartile of 5 μmol/l ADP-induced post-treatment PA. Results: Current smokers on chronic clopidogrel therapy displayed significantly lower PA and ADP-stimulated active GP IIb/IIIa expression compared with NS (p ≤ 0.0008 for both). Similarly, CS treated with 600 mg of clopidogrel displayed greater platelet inhibition and lower active GP IIb/IIIa expression compared with NS (p ≤ 0.05). In a multivariate Cox regression analysis, current smoking was an independent predictor of low PA (p = 0.0001). Conclusion: Clopidogrel therapy in CS is associated with increased platelet inhibition and lower aggregation as compared with NS. The mechanism of the smoking effect deserves further study and may be an important cause of response variability to clopidogrel therapy.

AB - Objectives: The purpose of this study was to examine the effect of cigarette smoking on the platelet response to clopidogrel. Background: Response variability to clopidogrel therapy has been demonstrated. Clopidogrel is metabolically activated by several hepatic cytochrome P450 (CYP) isoenzymes, including CYP1A2. Cigarette smoking induces CYP1A2 and may, therefore, enhance the conversion of clopidogrel to its active metabolite. Methods: Among 259 consecutive patients undergoing elective coronary stenting; 120 were on chronic clopidogrel therapy and were not loaded; and 139 were clopidogrel naïve and were loaded with 600 mg. There were 104 current smokers (CS) and 155 nonsmokers (NS). The adenosine diphosphate (ADP)-stimulated platelet aggregation (PA) was assessed by conventional aggregometry. The ADP-stimulated total and active glycoprotein (GP) IIb/IIIa expression were assessed with flow cytometry. Low PA was defined as the lowest quartile of 5 μmol/l ADP-induced post-treatment PA. Results: Current smokers on chronic clopidogrel therapy displayed significantly lower PA and ADP-stimulated active GP IIb/IIIa expression compared with NS (p ≤ 0.0008 for both). Similarly, CS treated with 600 mg of clopidogrel displayed greater platelet inhibition and lower active GP IIb/IIIa expression compared with NS (p ≤ 0.05). In a multivariate Cox regression analysis, current smoking was an independent predictor of low PA (p = 0.0001). Conclusion: Clopidogrel therapy in CS is associated with increased platelet inhibition and lower aggregation as compared with NS. The mechanism of the smoking effect deserves further study and may be an important cause of response variability to clopidogrel therapy.

KW - clopidogrel

KW - platelets

KW - smoking

KW - stenting

UR - http://www.scopus.com/inward/record.url?scp=48449101872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449101872&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2008.04.045

DO - 10.1016/j.jacc.2008.04.045

M3 - Article

C2 - 18687246

AN - SCOPUS:48449101872

VL - 52

SP - 531

EP - 533

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 7

ER -